(News Bulletin 247) – MedinCell today announced the success of its Global Offering for a final amount of 25.1 million euros to French and international investors via a Private Placement, and to French retail investors via the platform PrimaryBid.
The net proceeds of the Global Offering reinforce the funds already available to the Company. Its purpose is to contribute to the financing of preclinical and clinical activities for the Company’s programs, new product formulation activities, investments in the expansion and improvement of the laboratory in Montpellier and the research and development of new technology.
Christophe Douat, Chairman of the Management Board of MedinCell, said: ‘The team is motivated and eager to continue developing our portfolio, all of whose product candidates are based on the same technology as UZEDYTM, our first product which has just been FDA approved. We already have two other programs in phase 3. Our impact on the health of patients around the world is set to increase greatly. ‘
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
